Literature DB >> 8115630

Adenomyosis: prospective comparison of MR imaging and transvaginal sonography.

S M Ascher1, L L Arnold, R H Patt, J J Schruefer, A S Bagley, R C Semelka, R K Zeman, J A Simon.   

Abstract

PURPOSE: To prospectively compare conventional spin-echo magnetic resonance (MR) imaging and transvaginal sonography for the diagnosis of adenomyosis.
MATERIALS AND METHODS: Twenty women with clinically suspected adenomyosis underwent MR imaging and transvaginal sonography performed within 3 months of each other. Pathologic proof was obtained in all cases.
RESULTS: Seventeen patients were proved to have adenomyosis. The correct diagnosis was achieved with MR imaging in 15 of 17 cases. One false-positive and two false-negative diagnoses were made with MR imaging. With transvaginal sonography, nine of 17 cases of adenomyosis were correctly diagnosed. One false-positive and eight false-negative diagnoses occurred. The most frequent cause of false-negative diagnoses with transvaginal sonography was the misinterpretation of adenomyosis as leiomyomas (seven cases).
CONCLUSION: MR imaging is significantly better (P < .02) than transvaginal sonography in the diagnosis of adenomyosis.

Entities:  

Mesh:

Year:  1994        PMID: 8115630     DOI: 10.1148/radiology.190.3.8115630

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

2.  MRI, US or real-time virtual sonography in the evaluation of adenomyosis?

Authors:  Valeria Vinci; Matteo Saldari; Maria Eleonora Sergi; Silvia Bernardo; Giuseppe Rizzo; Maria Grazia Porpora; Carlo Catalano; Lucia Manganaro
Journal:  Radiol Med       Date:  2017-02-15       Impact factor: 3.469

3.  Tumor vascular pattern and blood flow impedance in the differential diagnosis of leiomyoma and adenomyosis by color Doppler sonography.

Authors:  C H Chiang; M Y Chang; J J Hsu; T H Chiu; K F Lee; T T Hsieh; Y K Soong
Journal:  J Assist Reprod Genet       Date:  1999-05       Impact factor: 3.412

4.  Elastosonography: a possible new tool for diagnosis of adenomyosis?

Authors:  Marco Tessarolo; Luca Bonino; Marco Camanni; Francesco Deltetto
Journal:  Eur Radiol       Date:  2011-01-26       Impact factor: 5.315

5.  Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis.

Authors:  Dae Chul Jung; Man Deuk Kim; Young Taik Oh; Jong Yun Won; Do Yun Lee
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

6.  Uterine artery embolization for the treatment of adenomyosis.

Authors:  Meridith J Englander
Journal:  Semin Intervent Radiol       Date:  2008-12       Impact factor: 1.513

7.  Can measurement of apparent diffusion coefficient before treatment predict the response to uterine artery embolization for adenomyosis?

Authors:  Yaewon Park; Man Deuk Kim; Dae Chul Jung; Shin Jae Lee; Gyoungmin Kim; Sung Il Park; Jong Yun Won; Do Yun Lee
Journal:  Eur Radiol       Date:  2014-12-07       Impact factor: 5.315

8.  Role of imaging in female infertility [Dr. K.M. Rai Memorial Oration Award].

Authors:  Rajul Rastogi
Journal:  Indian J Radiol Imaging       Date:  2010-08

9.  Use of Uterine Characteristics to Improve Fertility-Sparing Diagnosis of Adenomyosis.

Authors:  Amanda M Ecker; Dina Chamsy; R Marshall Austin; Richard S Guido; Ted T M Lee; Suketu M Mansuria; Noah B Rindos; Nicole M Donnellan
Journal:  J Gynecol Surg       Date:  2018-08-01

10.  Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis.

Authors:  Rosa Moghadam; Ruth B Lathi; Babac Shahmohamady; Naghmeh S Saberi; Ceana H Nezhat; Farr Nezhat; Camran Nezhat
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.